BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12030786)

  • 1. Anticancer therapy with novel tubulin-interacting drugs.
    Kavallaris M; Verrills NM; Hill BT
    Drug Resist Updat; 2001 Dec; 4(6):392-401. PubMed ID: 12030786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtubule alterations and resistance to tubulin-binding agents (review).
    Drukman S; Kavallaris M
    Int J Oncol; 2002 Sep; 21(3):621-8. PubMed ID: 12168109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubulin and microtubules as targets for anticancer drugs.
    Hadfield JA; Ducki S; Hirst N; McGown AT
    Prog Cell Cycle Res; 2003; 5():309-25. PubMed ID: 14593726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on tubulin-binding agents.
    Attard G; Greystoke A; Kaye S; De Bono J
    Pathol Biol (Paris); 2006 Mar; 54(2):72-84. PubMed ID: 16545633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epothilones: mechanism of action and biologic activity.
    Goodin S; Kane MP; Rubin EH
    J Clin Oncol; 2004 May; 22(10):2015-25. PubMed ID: 15143095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
    Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
    Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential mechanisms of resistance to microtubule inhibitors.
    Kavallaris M; Annereau JP; Barret JM
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S22-7. PubMed ID: 18538175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum.
    Fennell BJ; Carolan S; Pettit GR; Bell A
    J Antimicrob Chemother; 2003 Apr; 51(4):833-41. PubMed ID: 12654761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule active agents: beyond the taxane frontier.
    Morris PG; Fornier MN
    Clin Cancer Res; 2008 Nov; 14(22):7167-72. PubMed ID: 19010832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel agents that target tublin and related elements.
    Rowinsky EK; Calvo E
    Semin Oncol; 2006 Aug; 33(4):421-35. PubMed ID: 16890797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products as antimitotic agents.
    Dall'Acqua S
    Curr Top Med Chem; 2014; 14(20):2272-85. PubMed ID: 25434355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubules: a dynamic target in cancer therapy.
    Pasquier E; Kavallaris M
    IUBMB Life; 2008 Mar; 60(3):165-70. PubMed ID: 18380008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
    Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubulin as a target for anticancer drugs.
    von Angerer E
    Curr Opin Drug Discov Devel; 2000 Sep; 3(5):575-84. PubMed ID: 19649885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
    Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH
    Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
    Cortes J; Baselga J
    Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol.
    Clark EA; Hills PM; Davidson BS; Wender PA; Mooberry SL
    Mol Pharm; 2006; 3(4):457-67. PubMed ID: 16889440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microtubules and antineoplastic drugs].
    Arioka H; Saijo N
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):583-90. PubMed ID: 7908790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.